Researchers at Mass General Brigham have developed a series of artificial intelligence (AI) tools that uses machine learning ...
1d
MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026
MyOme, a leader in clinical whole-genome analysis, announced an advancement in rare disease diagnostics at the American College of Medical Genetics and Genomics (ACMG) Annual Meeting. By integrating ...
Natera has recently launched Zenith genomics, a next-generation whole genome sequencing assay developed with MyOme to improve rare disease detection, leveraging long-read confirmation and a whole ...
Barclays 28th Annual Global Healthcare Conference March 11, 2026 12:00 PM EDTCompany ParticipantsRobin Cowie - CFO, Secretary ...
Researchers at Mass General Brigham have developed a series of artificial intelligence (AI) tools that uses machine learning to identify individuals who may be at risk for intimate partner violence ...
Rising national health expenditures and high administrative overhead create a compelling but not definitive business case for AI-enabled automation across billing, claims, and compliance functions.
MyOme Debuts Zenithtm Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026
MyOme, a leader in clinical whole-genome analysis, announced an advancement in rare disease diagnostics at the American College of Medical Genetics and Genomics (ACMG) Annual Meeting. By integrating ...
The barge, filled with scrap metal, was being towed to Camden when a fire broke out. The barge was towed in circles around ...
3d
How Bendigo Bank turned a data challenge from Up into the streaming backbone powering its AI future
For a 168-year-old institution, transformation rarely happens overnight, particularly in the banking sector, which is well-known for its legacy systems. But at Bendigo Bank, the past eight years have ...
Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced the commercial launch of Zenith genomics, its next-generation whole genome sequencing assay designed to ...
Leerink Global Healthcare Conference 2026 March 11, 2026 8:00 AM EDTCompany ParticipantsSam Samad - Executive VP ...
In a March 9 report, Stifel Financial Corp. analyst Justin Keywood maintained a “Buy” rating and $9.00 target on WELL Health Technologies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results